FIELD: biotechnology, molecular biology, genetic engineering. SUBSTANCE: invention relates to construction of recombinant plasmid DNA determining smallpox virus growth factor synthesis and preparing the strain containing the indicated plasmid. Strain is used as a producer of smallpox virus growth factor fused with β-galactosidase. Recombinant smallpox virus growth factor can be used in future as mitogen for epithelial cells, for cell proliferation and wound healing. EFFECT: plasmid indicated above. 2 cl, 3 dwg
Authors
Dates
1997-09-10—Published
1993-10-25—Filed